Christa Braun-Inglis, associate researcher and oncology nurse practitioner at the University of Hawaiʻi Cancer Center, received the Mary Pazdur Award for her leadership, innovation and efforts to remove barriers preventing Advanced Practice Providers (APPs) from participating in clinical trials.
An advocate for including APPs in National Cancer Institute-sponsored research, Braun-Inglis has expanded their role in clinical trials, enhancing access to innovative therapies, particularly for underserved communities. By bridging clinical care and research, she is driving improvements in patient outcomes and advancing standards in cancer care.
“I am honored and humbled to have received the Mary Pazdur Award,” Braun-Inglis said. “I believe in the value that advanced practice providers bring to oncology care teams. My passion to empower APPs in clinical research not only increases patient access to clinical trials but also improves outcomes. Mary was an amazing advanced practice provider in her own right, and to be recognized by my peers with this award is truly incredible.”
Braun-Inglis also practices at Hawaiʻi Pacific Health in the Breast Medical Oncology division. After earning her nursing degree and master’s at UH, she became a nurse practitioner specializing in medical oncology and earned her Doctorate of Nursing Practice in 2021.
She was also recently awarded the 2024 David King Community Clinical Scientist Award by the Association of Community Cancer Centers and the 2023 National Cancer Instituteʻs Directorʻs Award.
Brain-Inglis received the award on November 16 at the Journal of the Advanced Practitioner in Oncology conference in Dallas, Texas. The award is named in memory of Mary Pazdur, a nurse practitioner, who dedicated her career to her patients and family.
